222 related articles for article (PubMed ID: 28935400)
1. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T
Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400
[TBL] [Abstract][Full Text] [Related]
2. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
[TBL] [Abstract][Full Text] [Related]
3. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
Ophthalmic Oncology Task Force
Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
[TBL] [Abstract][Full Text] [Related]
4. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
5. Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
Bellerive C; Aziz HA; Bena J; Wilkinson A; Suh JH; Plesec T; Singh AD
Am J Ophthalmol; 2017 May; 177():9-16. PubMed ID: 28163118
[TBL] [Abstract][Full Text] [Related]
6. Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.
Stroup SP; Raheem OA; Palazzi KL; Liss MA; Mehrazin R; Kopp RP; Patel N; Cohen SA; Park SK; Patterson AL; Kane CJ; Millard F; Derweesh IH
Urology; 2013 Apr; 81(4):805-11. PubMed ID: 23414694
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
Wong W; Sundar G; Chee C; Zhao PS; Rajagopalan R; Gopal L
Singapore Med J; 2019 Sep; 60(9):474-478. PubMed ID: 31197380
[TBL] [Abstract][Full Text] [Related]
8. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
[TBL] [Abstract][Full Text] [Related]
9. Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features.
Kim JH; Park I; Lee JL
Cancer Chemother Pharmacol; 2016 Aug; 78(2):325-32. PubMed ID: 27324136
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China.
Liu YR; Zhu W; Zhang JL; Huang JQ; Zhao YZ; Zhang W; Han BH; Yao YH; Jiang LY; Li SQ
Clin Respir J; 2014 Apr; 8(2):206-12. PubMed ID: 24118906
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
12. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
[TBL] [Abstract][Full Text] [Related]
13. Co-occurring adverse events enable early prediction of progression-free survival in metastatic renal cell carcinoma patients treated with sunitinib: a hypothesis-generating study.
Kucharz J; Dumnicka P; Kuzniewski M; Kusnierz-Cabala B; Herman RM; Krzemieniecki K
Tumori; 2015; 101(5):555-9. PubMed ID: 26045121
[TBL] [Abstract][Full Text] [Related]
14. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
15. The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.
Al-Jamal RT; Cassoux N; Desjardins L; Damato B; Konstantinidis L; Coupland SE; Heimann H; Petrovic A; Zografos L; Schalenbourg A; Velazquez-Martin JP; Krema H; Bogdali A; Markiewicz A; Romanowska-Dixon B; Metz CH; Biewald E; Bornfeld N; Kiratli H; Bronkhorst IH; Jager MJ; Marinkovic M; Fili M; Seregard S; Frenkel S; Pe'er J; Salvi SM; Rennie IG; Rospond-Kubiak I; Kociecki J; Kiilgaard JF; Heegaard S; Cohen VM; Sagoo MS; Amiryan A; Saakyan S; Eide N; Krohn J; Midena E; Parrozzani R; Grange JD; Kilic E; Blasi MA; Saornil MA; Kivelä TT
Ophthalmology; 2016 Apr; 123(4):898-907. PubMed ID: 26854035
[TBL] [Abstract][Full Text] [Related]
16. UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.
Shields CL; Acaba-Berrocal LA; Selzer EB; Mayro EL; Newman JH; Malik K; Welch RJ; Shields JA
Retina; 2020 Feb; 40(2):204-213. PubMed ID: 31972789
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of UM and Association of Metastasis of Uveal Melanoma with Congenital Oculocutaneous Melanosis in Asian Patients: Analysis of 1151 Consecutive Eyes.
Zhou N; Zhang R; Liu Y; Wei W
Ophthalmol Retina; 2021 Nov; 5(11):1164-1172. PubMed ID: 33444806
[TBL] [Abstract][Full Text] [Related]
18. Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.
Livne-Segev D; Gottfried M; Maimon N; Peer A; Neumann A; Hayat H; Kovel S; Sella A; Mermershtain W; Rouvinov K; Boursi B; Weitzen R; Berger R; Keizman D
Isr Med Assoc J; 2014 Jun; 16(6):347-51. PubMed ID: 25058995
[TBL] [Abstract][Full Text] [Related]
19. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
Park SJ; Oh CM; Yeon B; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
Ready NE; Pang HH; Gu L; Otterson GA; Thomas SP; Miller AA; Baggstrom M; Masters GA; Graziano SL; Crawford J; Bogart J; Vokes EE
J Clin Oncol; 2015 May; 33(15):1660-5. PubMed ID: 25732163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
